Back to Results
First PageMeta Content
Medicine / Carboxylic acids / Lactones / Diols / Pyrimidines / Rosuvastatin / Cerivastatin / Simvastatin / Lovastatin / Chemistry / Organic chemistry / Statins


Document Date: 2005-03-23 13:32:50

Open Document

Share Result on Facebook

City

Washington / DC / /

Company

Health ResearchGroup / AstraZeneca / M.D. / /

Country

United States / Canada / United Kingdom / /

Event

FDA Phase / Product Issues / Product Recall / /

IndustryTerm

statin drug applications / arterial imaging / manufacturing / /

MedicalCondition

full-blown rhabdomyolysis / casesof renal failure / muscle injury / myopathy / rive casesof rhabdomyolysis / additional casesof rhabdomyolysis / incidencesof proteinuria / numerous instancesof myopathy / associatedwith multiple casesof rhabdomyolysis / serious kidney injury / causescharacterizedby severemuscle injury / CP1 Two casesof renal failure / signalsof renal injury / renal disease / decreasingheart attacksand strokes / coronary heart disease / clinical syndrome / chronic use drug / proteinuria / heterozygousfamilial hypercholesterolemia / I. Myopathy / hematuria / muscle pain / casesof rhabdomyolysis / rhabdomyolysis / single caseof rhabdomyolysis / kidney failure / renal insufficiency / Stat&associated myopathy / pains / renal failure / caseof renal insufficiency / /

Organization

Food and Drug Administration / Cardio-Renal Advisory Committee / U.K. Medicinesand HealthcareProductsRegulatory Agency / Endocrine and Metabolic Drugs Advisory Committee / American Medical Association / DEPARTMENT OF HEALTH / Advisory Committee / /

Person

Sidney M. Wolfe / Richard Horton / John Blenkinsopp / Ann Pharmacother / /

Position

Director / medical officer / /

Product

simvastatin / cyclosporine / Crestor / erythromycin / Baycol / cerivastatin / ketoconazole / alli / lovastatin / muscle toxicity with Baycol / Phase4 / December2003 / statementsin drug / statin Baycol / /

PublishedMedium

the Journal of the American Medical Association / /

SocialTag